Cardiac soluble guanylate cyclase protects against the cardiac dysfunction induced by chronic doxorubicin treatment in mice
View/ Open
Author
Swinnen, Melissa
Gillijns, Hilde
Caluwé, Ellen
Tainsh, Robert E
Nathan, Daniel I
Allen, Kaitlin
Bartunek, Jozef
Brouckaert, Peter
Bloch, Kenneth D
Janssens, Stefan P
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1186/2050-6511-16-S1-A96Metadata
Show full item recordCitation
Vandenwijngaert, S., M. Swinnen, H. Gillijns, E. Caluwé, R. E. Tainsh, D. I. Nathan, K. Allen, et al. 2015. “Cardiac soluble guanylate cyclase protects against the cardiac dysfunction induced by chronic doxorubicin treatment in mice.” BMC Pharmacology & Toxicology 16 (Suppl 1): A96. doi:10.1186/2050-6511-16-S1-A96. http://dx.doi.org/10.1186/2050-6511-16-S1-A96.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565628/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:22856932
Collections
- HMS Scholarly Articles [17917]
Contact administrator regarding this item (to report mistakes or request changes)